4//SEC Filing
YOUNG WILLIAM D 4
Accession 0001415889-22-004339
CIK 0001583107other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 9:34 PM ET
Size
7.0 KB
Accession
0001415889-22-004339
Insider Transaction Report
Form 4
YOUNG WILLIAM D
Director
Transactions
- Award
Ordinary Shares
2022-04-26+9,852→ 78,010 total - Award
Share Option (Right to Buy)
2022-04-26+28,000→ 28,000 totalExercise: $10.15Exp: 2032-04-25→ Ordinary Shares (28,000 underlying)
Footnotes (1)
- [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001217420
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 9:34 PM ET
- Size
- 7.0 KB